What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
His main research concerns Prostate cancer, Cancer research, TMPRSS2, Pathology and Fusion gene.
The Prostate cancer study combines topics in areas such as Transcriptional Regulator ERG and Prostate.
His Cancer research research integrates issues from Carcinogenesis, Cancer, Metastasis, Gene expression profiling and Molecular biology.
His TMPRSS2 study incorporates themes from Gene rearrangement, ETV1 and ETS transcription factor family.
Rohit Mehra interconnects Mutation, Protein microarray and HRAS in the investigation of issues within Pathology.
His work deals with themes such as Cell and In situ hybridization, which intersect with Fusion gene.
His most cited work include:
- Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer (3179 citations)
- Integrative clinical genomics of advanced prostate cancer (1675 citations)
- Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression (1590 citations)
What are the main themes of his work throughout his whole career to date?
Prostate cancer, Cancer research, Internal medicine, Pathology and Oncology are his primary areas of study.
His Prostate cancer research is multidisciplinary, incorporating elements of Prostate and Metastasis.
His Cancer research study integrates concerns from other disciplines, such as TMPRSS2, Fusion gene, Chromoplexy, ETV1 and Androgen receptor.
His biological study spans a wide range of topics, including Transcriptional Regulator ERG and ETS transcription factor family.
His Internal medicine study frequently draws connections between related disciplines such as Endocrinology.
His Oncology research is multidisciplinary, relying on both MEDLINE, Hazard ratio, Confidence interval, Proportional hazards model and Radiation therapy.
He most often published in these fields:
- Prostate cancer (52.83%)
- Cancer research (34.59%)
- Internal medicine (32.39%)
What were the highlights of his more recent work (between 2019-2021)?
- Prostate cancer (52.83%)
- Internal medicine (32.39%)
- Pathology (31.76%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Prostate cancer, Internal medicine, Pathology, Oncology and Renal cell carcinoma.
His Prostate cancer research includes elements of Cancer research, Metastasis, Cohort and MEDLINE.
The concepts of his Cancer research study are interwoven with issues in Tumor microenvironment, Immune system, Cell and Androgen receptor.
His research in Pathology intersects with topics in Biomarker, Genitourinary system and Adenocarcinoma.
His Oncology study combines topics from a wide range of disciplines, such as Randomized controlled trial, Retrospective cohort study, Meta-analysis, Androgen deprivation therapy and Radiation therapy.
His studies in Renal cell carcinoma integrate themes in fields like Immunohistochemistry, Surgical pathology, Eosinophilic and TFE3.
Between 2019 and 2021, his most popular works were:
- Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma (43 citations)
- The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer. (18 citations)
- Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2 . (15 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
His scientific interests lie mostly in Prostate cancer, Pathology, Prostatectomy, Internal medicine and Cancer.
Prostate cancer is closely attributed to MEDLINE in his work.
His Pathology research is multidisciplinary, incorporating perspectives in Biomarker and Genitourinary system.
His Prostatectomy study also includes
-
Urology together with Hormone therapy, Prostate-specific antigen and Hazard ratio,
-
Carcinoma that intertwine with fields like Prospective cohort study, Metastasis, Confidence interval, Framingham Risk Score and Odds ratio.
In his study, which falls under the umbrella issue of Internal medicine, Androgen deprivation therapy is strongly linked to Oncology.
His research on Cancer also deals with topics like
-
Biopsy that intertwine with fields like Clinical significance, Predictive value of tests, Prostate and Prostate biopsy,
-
Cohort, which have a strong connection to Prostate needle biopsy, Interquartile range, Epidemiology and Cohort study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
